Home NDC 63323-342-41 NDC 63323-342-41 - Cefoxitin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63323-342
Requested NDC 63323-342-41
Package NDCs from labels 63323-342-41, 63323-342-29, 63323-342-01, 63323-342-25
Manufacturer Fresenius Kabi USA, LLC | ACS Dobfar SPA
Effective date 2023-07-10
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-342-01 Cefoxitin 1 in 1 VIAL POWDER, FOR SOLUTION 1 8 63323-342-25 Cefoxitin 25 in 1 CARTON POWDER, FOR SOLUTION 25 8 63323-342-29 Cefoxitin 25 in 1 CARTON POWDER, FOR SOLUTION 25 6 63323-342-41 Cefoxitin 1 in 1 VIAL POWDER, FOR SOLUTION 1 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-342 CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC
] 8 Current NDC, Legacy NDC, 2 package rows 20221004_d02170ff-65aa-48b8-a922-94271c46ffa7.zip 63323-342 CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 6 Current NDC, Legacy NDC, 2 package rows 20230721_2a9d1e7b-96ee-4e6c-a1e8-47b76b924422.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEFOXITIN SODIUM ACTIVE INGREDIENT Q68050H03T CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 CEFOXITIN ACTIVE MOIETY 6OEV9DX57Y CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 CEFOXITIN SODIUM ACTIVE INGREDIENT Q68050H03T CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 1 CEFOXITIN ACTIVE MOIETY 6OEV9DX57Y CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 11 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Cefoxitin CEFOXITIN WG Critical Care, LLC 658a0dc6-6da5-44dc-94f2-1211619297f7 2026-08-24 Warnings, Adverse reactions Exact identifier application number: ANDA065414 rxcui: 1665102 rxcui: 1665107 unii: Q68050H03T Cefoxitin CEFOXITIN WG Critical Care, LLC 91ac4c14-8dd8-4efe-a462-d1c488a6184f 2025-11-12 Warnings, Adverse reactions Exact identifier application number: ANDA065414 rxcui: 1665102 rxcui: 1665107 unii: Q68050H03T Cefoxitin CEFOXITIN Hikma Pharmaceuticals USA Inc. 6a4a2afa-4f00-41d4-bd6d-baa0a95f6929 2025-03-03 Warnings, Adverse reactions Exact identifier unii: Q68050H03T Cefoxitin CEFOXITIN Hikma Pharmaceuticals USA Inc. d2c449b9-5624-4166-95b1-d7813b3d0445 2024-04-11 Warnings, Adverse reactions Exact identifier rxcui: 1665102 rxcui: 1665107 unii: Q68050H03T Cefoxitin CEFOXITIN Sagent Pharmaceuticals b272ef9c-4d83-4ee2-b9cc-477440822cca 2024-01-03 Warnings, Adverse reactions Exact identifier application number: ANDA065414 rxcui: 1665102 rxcui: 1665107 unii: Q68050H03T Cefoxitin CEFOXITIN WG Critical Care, LLC f5288962-caee-4771-8229-df9cdefcfa67 2023-10-16 Boxed warning, Warnings, Adverse reactions Exact identifier unii: Q68050H03T Cefoxitin CEFOXITIN SODIUM Fresenius Kabi USA, LLC 2a9d1e7b-96ee-4e6c-a1e8-47b76b924422 2023-07-10 Warnings, Adverse reactions Exact identifier application number: ANDA065414 ndc (package): 63323-342-29 ndc (package): 63323-342-41 ndc (package): 63323-341-29 ndc (package): 63323-341-41 ndc (product): 63323-341 ndc (product): 63323-342 ndc11 (package): 63323034241 rxcui: 1665102 rxcui: 1665107 spl id: 0fffe10d-e5bc-4a0c-ae5b-bbf4095990ba spl set id: 2a9d1e7b-96ee-4e6c-a1e8-47b76b924422 unii: Q68050H03T Cefoxitin CEFOXITIN SODIUM Fresenius Kabi USA, LLC d02170ff-65aa-48b8-a922-94271c46ffa7 2022-09-23 Warnings, Adverse reactions Exact identifier application number: ANDA065414 ndc (package): 63323-341-25 ndc (package): 63323-342-01 ndc (package): 63323-341-01 ndc (package): 63323-342-25 ndc (product): 63323-341 ndc (product): 63323-342 rxcui: 1665102 rxcui: 1665107 spl id: 9f457501-b963-49c0-89a3-4228eb493895 spl set id: d02170ff-65aa-48b8-a922-94271c46ffa7 unii: Q68050H03T Cefoxitin CEFOXITIN SAMSON MEDICAL TECHNOLOGIES LLC ea6dba56-5d9c-463a-b1d9-f7af5b602ed9 2020-11-16 Boxed warning, Warnings, Adverse reactions Exact identifier unii: Q68050H03T Cefoxitin CEFOXITIN Sagent Pharmaceuticals 4c6f7665-204f-6c69-7669-61204d756e6e 2020-06-09 Boxed warning, Warnings, Adverse reactions Exact identifier unii: Q68050H03T Cefoxitin and Dextrose CEFOXITIN SODIUM B. Braun Medical Inc. 6c7e9485-1ede-411c-8c46-911439332864 2019-07-29 Warnings, Adverse reactions Exact identifier rxcui: 1665102 rxcui: 1665107 unii: Q68050H03T
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.